Medrysone

A week glucocorticoid effective in the treatment of allergic conjunctivitis and possibly in other mild superficial ocular inflammatory conditions. Untoward effects are stinging and burning sensations after instillation.


Brands
Adult Dose
Dose: 1%
Single Dose: 1 (1)
Frequency: As recommended.
Route: Ophthalmic
Instructions: As Required.To be given as drops.
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin and belongs to Steroid and steroid derivatives. . The Molecular Weight of Medrysone is 344.50.
Contraindications
Medrysone is contraindicated in conditions like Uveitis,Iritis,Hypersensitivity to any component of product.
Effects
The severe or irreversible adverse effects of Medrysone, which give rise to further complications include Reduced visual function, Increased IOP (intraocular pressure).
Indications
Medrysone is primarily indicated in conditions like Allergy, Eye inflammation.
Interactions
No data regarding the interactions of Medrysone was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Eye Susp Store Below 40°C. Do not Freeze. Protect from Sunlight.
Warnings
Medrysone should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy. Use nasal steroids with caution until healing has occurred. It should be used with caution in patients with eye problems. Using contact lenses during treatment with this drug may increase chance of developing eye infection.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.